Status:
COMPLETED
Gut Microbiota, "Spark and Flame" of COVID-19 Disease
Lead Sponsor:
Universidade Nova de Lisboa
Collaborating Sponsors:
Hospital de São Francisco Xavier, Centro Hospitalar de Lisboa Ocidental
Centro Hospitalar Universitário São João
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Elderly, hypertension, diabetes and cardiovascular diseases are risk factors for COVID-19 morbility and mortality. However, the real reason for this is not yet understood. It is well documented that g...
Detailed Description
In order to explore this hypothesis, we will analyse the gut microbiota of SARSCoV-2 infected patients categorized according to location: \[1\] ambulatory (self-isolation at home), \[2\] ward and \[1\...
Eligibility Criteria
Inclusion
- Adults of 18 years and above.
- COVID-19 patients.
Exclusion
- None.
Key Trial Info
Start Date :
April 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 16 2020
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT04355741
Start Date
April 20 2020
End Date
July 16 2020
Last Update
August 25 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital CUF Infante Santo, S.A.
Lisbon, Portugal
2
Hospital de São Francisco Xavier
Lisbon, Portugal
3
Centro Hospitalar Universitário São João
Porto, Portugal